Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» UCB Pays $34 Million and Pleads Guilty in Epilepsy Drug Fraud Case
UCB Pays $34 Million and Pleads Guilty in Epilepsy Drug Fraud Case
UCB Pays $34 Million and Pleads Guilty in Epilepsy Drug Fraud Case
Submitted by
admin
on June 9, 2011 - 10:49pm
Source:
NY Times, NY
News Tags:
UCB Pharmaceuticals
Keppra
epilepsy
off-label
Headline:
UCB Pays $34 Million and Pleads Guilty in Epilepsy Drug Fraud Case
Do Not Allow Advertisers to Use My Personal information
